INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,897,200 | -22.5% | 60,000 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $2,446,800 | +4.2% | 60,000 | -4.8% | 0.01% | 0.0% |
| Q1 2023 | $2,348,010 | -74.4% | 63,000 | -76.0% | 0.01% | -77.3% |
| Q4 2022 | $9,176,070 | -49.5% | 263,000 | -19.1% | 0.02% | -51.1% |
| Q3 2022 | $18,187,000 | +99.7% | 325,000 | +84.7% | 0.04% | +114.3% |
| Q2 2022 | $9,109,000 | -26.7% | 175,978 | +2.9% | 0.02% | -12.5% |
| Q1 2022 | $12,425,000 | -85.4% | 170,978 | -76.2% | 0.02% | -84.3% |
| Q4 2021 | $84,835,000 | -11.9% | 717,478 | 0.0% | 0.15% | -19.5% |
| Q3 2021 | $96,250,000 | +28.4% | 717,478 | +55.0% | 0.19% | +29.3% |
| Q2 2021 | $74,961,000 | – | 462,978 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |